Botanical species · safety record

Cruciata laevipes

The EFSA Compendium of Botanicals holds 8 constituent measurements for Cruciata laevipes. This page reports what those source records contain and how to reach them. It carries no effect estimate, no dose and no recommendation.

Accepted name in source: Cruciata laevipes Opiz.

8Constituent measurements

0Safety records

4Cited sources

0Licensed products (Canada)

Also recorded as

Galium cruciata (L.) Scop.

Synonyms are carried from the source compendium. A species may be traded and studied under more than one name, which is exactly how a safety record gets lost.

Regulatory presence

No Health Canada licensed natural health product in the snapshot names this species as a medicinal ingredient under this exact binomial. Absence here means absence from this one register under this one name, not absence from trade, and not a safety verdict.

What the records describe

Constituents measured

Plant parts

Preparations

Recorded constituents

What analytical work has found in this species, at which plant part and preparation. A measured constituent is a fact about material, not about effect.

Substance	Plant part	Preparation	Concentration	Analytical method	Source
Epoxides	Aerial part of plants	Essential oil	2.1 Gram/100 gram	LC-MS	Resolve DOI
Eugenol	Aerial part of plants	Essential oil	1.8 Gram/100 gram	LC-MS	Resolve DOI
Coumarins	Aerial part of plants	—	—	—	No resolvable identifier
Daphnetin glucoside	Aerial part of plants	Solvent extraction	—	High Performance Liquid Chromatography (HPLC)/Liquid Chromatography (LC)	No resolvable identifier
Daphnin	Aerial part of plants	Solvent extraction	—	High Performance Liquid Chromatography (HPLC)/Liquid Chromatography (LC)	No resolvable identifier
Scopoletin	Live plants	Solvent extraction	—	Standard Chromatographic tests (paper- thin layer- and column chromatography)	No resolvable identifier
Tannins	Aerial part of plants	—	—	—	No resolvable identifier
Umbelliferone	Live plants	Solvent extraction	—	Standard Chromatographic tests (paper- thin layer- and column chromatography)	No resolvable identifier

Cited sources

The literature the compendium cites for this species. Metatron Health has no relationship with these authors or journals and earns nothing from citing them.

Il'ina, T. V., Kovaleva, A. M., Goryachaya, O. V., Vinogradov, B. A. Terpenoids and aromatic compounds from essential oils of Cruciata laevipes and C. glabra. CHEMISTRY OF NATURAL COMPOUNDS, 2013, vol. 48, no. 6, p. 1106-1108. DOI
Borisov, M. I. Coumarins of the genus Asperula and Galium. Khimiya Prirodnykh Soedinenii, 1974.
Borisov, M. I., Borisyuk, Yu. G. Phytochemical investigation of Galium cruciata. Farmatsevtichnii Zhurnal (Kiev), 1965, p. 63-66.
Mitova, MI., Anchev, ME., Panev, SG., Handjieva, NV., Popov, SS. Coumarins and iridoids from Crucianella graeca, Cruciata glabra, Cruciata laevipes and Cruciata pedemontana (Rubiaceae). ZEITSCHRIFT FUR NATURFORSCHUNG C-A JOURNAL OF BIOSCIENCES, 1996, vol. 51, no. 9-10, p. 631-634.

Boundary

A constituent measurement is a fact about material at a stated preparation, not a statement about what that material does in a person. An adverse-effect or genotoxicity record is an observation reported in a source, most often in an animal or laboratory model. Neither is a Metatron Health conclusion about causality, human risk or benefit, and the absence of a record is not proof that a preparation is safe. Nothing here is diagnosis, prescribing or individual medical care.

Continue

Independent literature